Qiagen (NYSE:QGEN) Valuation Check After Recent Share Price Swings

Qiagen (QGEN) is back on investors’ radar after recent share price swings, with the stock showing a small 1 day gain and ...

How QIAGEN’s (QGEN) Diagnostics Expansion Strengthens Its Takeover Appeal

Qiagen N.V. (NYSE:QGEN) is one of the 10 potential takeover targets with strong price momentum. The latest relevant ...
Fierce Biotech

Qiagen launches latest diagnostic for bloodstream infections

Qiagen is moving into syndromic testing for bloodstream infections with the launch of the Netherlands-based diagnostics maker ...
Nasdaq

QIAGEN Stock Gains Following the Acquisition of Genoox

QIAGEN N.V. QGEN recently signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.
FierceBiotech

Qiagen turns to Sophia Genetics to squeeze more data from next-gen sequencing tests

Qiagen’s next-generation sequencing tests are already used to look for genetic variants that may shed light on an individual’s specific case of cancer and potential treatment options, but the ...
Seeking Alpha

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide ...
Seeking Alpha

QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in 2028 VENLO, Netherlands-- ...
Business Wire

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new ...
Nasdaq

QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth

ESG commitments recognized as strategic business investments bringing value to stakeholders, including customers and employees // Environment: 15% reduction in Scope 1 and 2 emissions in 2023 through ...
The Globe and Mail

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free ...
The Motley Fool

Here's How Qiagen Trounced Q1 Estimates

Qiagen reported first-quarter revenue of $372.1 million. This reflected a 7% increase from the prior-year period's revenue total of $348.7 million. It also handily beat the average analysts' Q1 ...
Business Wire

QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ...